Evidence map›Paper›PMID 31217870›Full record

ArticleAmerican journal of translational research2019

MiR-21b-3p protects NS2OY cells against oxygen-glucose deprivation/reperfusion-induced injury by down-regulating cyclooxygenase-2.

Xiaona Wu, Kairun Peng, Huai Huang, Zhensheng Li, Wei Xiang, Wenting Deng, Liu Liu, Wei Li, Tao Zhang

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaona WuDepartment of Neurology, General Hospital of Southern Theater Command, PLA Guangzhou, Guangdong, People's Republic of China.
Kairun PengDepartment of Neurology, General Hospital of Southern Theater Command, PLA Guangzhou, Guangdong, People's Republic of China.
Huai HuangDepartment Two of Nerve Rehabilitation, Guangzhou General Hospital, Guangzhou Military Region Guangzhou, Guangdong, People's Republic of China.
Zhensheng LiDepartment of Neurology, General Hospital of Southern Theater Command, PLA Guangzhou, Guangdong, People's Republic of China.
Wei XiangDepartment of Neurology, General Hospital of Southern Theater Command, PLA Guangzhou, Guangdong, People's Republic of China.
Wenting DengDepartment of Neurology, General Hospital of Southern Theater Command, PLA Guangzhou, Guangdong, People's Republic of China.
Liu LiuDepartment of Neurology, General Hospital of Southern Theater Command, PLA Guangzhou, Guangdong, People's Republic of China.
Wei LiGeneral Hospital of Northern Theater Command, PLA Shenyang, Liaoning, People's Republic of China.
Tao ZhangDepartment of Orthopaedics, General Hospital of Southern Theater Command, PLA Guangzhou, Guangdong, People's Republic of China.
General Hospital of Guangzhou Military Command · CNGeneral Hospital of Shenyang Military Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have shown abnormal expression levels of cyclooxygenase-2 (COX-2) and miR-21b-3p in cerebral ischemia-reperfusion (I/R) rat models. Decreased COX-2 expression could reduce brain injury and thus could be a target of miR-21b-3p according to the miRNA databases (miRDB) analysis. However, its functions and underlying mechanisms in I/R injury remain unclear. In our study, we have established an oxygen/glucose deprivation and reperfusion (OGD/R) model by using NS2OY cells. The expression of miR-21b-3p and COX-2 was determined by quantitative real-time PCR or Western blot, and the fluorescence intensities were detected by fluorescence in situ hybridization (FISH) or immunofluorescence. After transfection and OGD/R treatments, the functions of miR-21b-3p and COX-2 on cell viability and apoptosis were detected using cell-counting kit 8, Edu staining, flow cytometry and Hoechst staining, respectively. Finally, dual-luciferase reporter assay was used to explore the relationship between miR-21-b-3p and COX-2. The results have showed that COX-2 mRNA and protein expression were significantly increased; however, the expression of miR-21b-3p was remarkably reduced in NS2OY cells after OGD/R treatment. The changes were most remarkable in OGD 2 h/R24 group. Function analysis has showed that when NS2OY cells were exposed to OGD/R injury, overexpressed miR-21b-3p significantly downregulated COX-2 expression, increased cell viability and decreased apoptosis. In addition, knocking down the expression of COX-2 could also increase cell viability and decrease apoptosis. Dual-luciferase reporter assays showed miR-21b-3p as the target of 3'-UTR of COX-2. Therefore, we concluded that OGD/R-induced injury by down-regulating COX-2.

Indexed as

apoptosiscell viabilitycyclooxygenase-2miR-21b-3pOxygen/glucose deprivation and reperfusion

Identifiers

PMID31217870
PMCPMC6556624
OpenAlexW2997370786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.